Intrathecal baclofen therapy vs conventional medical management for severe poststroke spasticity

To cite: Creamer M, Cloud G, Kossmehl P, et al. J Neurol Neurosurg Psychiatry 2018;89:642-650.

Read the full article here:
http://dx.doi.org/10.1136/jnnp-2017-3...

Background: Intrathecal baclofen (ITB) is a treatment option for patients with severe poststroke spasticity (PSS) who have not reached their therapy goal with other interventions.

Conclusions: These data support the use of ITB therapy as an alternative to CMM for treatment of generalised PSS in adults.


Important Safety Information
Please refer to the important safety information accompanying this video.
You may also refer to the SynchroMed IITM Brief Statement and Lioresal® Full Prescribing Information via the links below the video or online at Medtronic.com/Synch2
Medtronic.com/Lioresal
Or call Medtronic at (800) 328- 0810